233 related articles for article (PubMed ID: 9489854)
1. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.
Gessa GL; Melis M; Muntoni AL; Diana M
Eur J Pharmacol; 1998 Jan; 341(1):39-44. PubMed ID: 9489854
[TBL] [Abstract][Full Text] [Related]
2. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
3. Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway.
Dhopeshwarkar A; Mackie K
J Pharmacol Exp Ther; 2016 Aug; 358(2):342-51. PubMed ID: 27194477
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake KD; Compton DR; Varga K; Martin BR; Kunos G
J Pharmacol Exp Ther; 1997 Jun; 281(3):1030-7. PubMed ID: 9190833
[TBL] [Abstract][Full Text] [Related]
5. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.
Diana M; Melis M; Gessa GL
Eur J Neurosci; 1998 Sep; 10(9):2825-30. PubMed ID: 9758152
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata.
Szabo B; Wallmichrath I; Mathonia P; Pfreundtner C
Neuroscience; 2000; 97(1):89-97. PubMed ID: 10771342
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.
Tyler K; Hillard CJ; Greenwood-Van Meerveld B
Eur J Pharmacol; 2000 Dec; 409(2):207-11. PubMed ID: 11104836
[TBL] [Abstract][Full Text] [Related]
8. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation.
Pistis M; Porcu G; Melis M; Diana M; Gessa GL
Eur J Neurosci; 2001 Jul; 14(1):96-102. PubMed ID: 11488953
[TBL] [Abstract][Full Text] [Related]
9. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus.
Miller AS; Walker JM
Eur J Pharmacol; 1996 May; 304(1-3):29-35. PubMed ID: 8813581
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
Pertwee RG; Griffin G; Lainton JA; Huffman JW
Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.
Cheer JF; Wassum KM; Heien ML; Phillips PE; Wightman RM
J Neurosci; 2004 May; 24(18):4393-400. PubMed ID: 15128853
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.
Gessa GL; Casu MA; Carta G; Mascia MS
Eur J Pharmacol; 1998 Aug; 355(2-3):119-24. PubMed ID: 9760025
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo.
Acquas E; Pisanu A; Marrocu P; Di Chiara G
Eur J Pharmacol; 2000 Aug; 401(2):179-85. PubMed ID: 10924924
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens.
Manzoni OJ; Bockaert J
Eur J Pharmacol; 2001 Jan; 412(2):R3-5. PubMed ID: 11165232
[TBL] [Abstract][Full Text] [Related]
17. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
Cadogan AK; Alexander SP; Boyd EA; Kendall DA
J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions.
Pistis M; Perra S; Pillolla G; Melis M; Gessa GL; Muntoni AL
Neuropharmacology; 2004 Jan; 46(1):115-25. PubMed ID: 14654103
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats.
Fattore L; Spano MS; Cossu G; Deiana S; Fratta W
Eur J Neurosci; 2003 Apr; 17(8):1723-6. PubMed ID: 12752390
[TBL] [Abstract][Full Text] [Related]
20. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.
Anderson JJ; Kask AM; Chase TN
Eur J Pharmacol; 1996 Jan; 295(2-3):163-8. PubMed ID: 8720580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
